This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. The cost per system was calculated retrospectively based on the number of tests performed per year.
Analysis of effectiveness
The analysis was based on the intention to treat principle. The primary health outcomes used in the analysis were the number of isolates grown in the media for each positive complex found in the specimens, average time to AFB detection and identification to the species level.
Effectiveness results
For the first study (with a 4% concentration of NaOH), the 4 specimens positive for M. tuberculosis complex grew isolates in both media; of the 25 specimens positive for M. avium-M. intracellulare complex, the isolates grown in MGIT medium only, BACTEC 460 medium only, and both, were 5, 8 and 12 (p>0.05). The analysis in terms of mean time to detection of AFB (for those commonly detected cases), yielded, for M. Tuberculosis complex, 20.75 days in MGIT and 14.5 days in BACTEC 460; M. Avium-M. intracellulare complex, 19.3 days in MGIT and 12.6 days in BACTEC 460 (p<0.05). The contamination rates in MGITs and BACTEC bottles were 29.8% and 5%, respectively. In the second study (6% NaOH concentration), the figures for isolates grown in MGIT only, BACTEC only, and both media, were respectively: of the 23 positive specimens for M. avium-M. intracellulare complex, 6, 5, and 11 (p>0.05); of the 10 positives for M. Gordonae, 2, 6, and 2; five out of 5 specimens positive for M. kansasii, M. fortuitum, M. marinum, and M. chelonae, were grown in both media. The mean times to detection of AFB in the 10 M. avium-M. intracellulare complex positive specimens were 13.7 and 10.7 days with MGIT and BACTEC, respectively (p<0.01). The corresponding figures for identification to the species level of these specimens were 18.9 and 14 days (p>0.05). The contamination rates for the MGIT and the BACTEC 460 systems were, respectively, 12.1% and 5.5% (p<0.001). Some comparisons could not be tested statistically due to low numbers.
Clinical conclusions
Overall bacterial contamination is less in BACTEC 460 than in MGIT, but contamination rates vary with the contaminating organisms in the specimens tested.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis, and only separate clinical outcomes were reported.
Direct costs
Quantities of resource use were reported separately from the costs. Cost items were reported separately. The costs measured were those associated with capital (equipment), labour, and reagents. The perspective adopted in the cost analysis was not explicitly reported. The cost calculation was carried out assuming 4,500 specimens analysed per year. The labour cost estimation was based on guidelines from the College of American Pathologists. The price year was not reported. The costs associated with laboratory, time, effort, and maintenance of a BACTEC 460 system, reprocessing of contaminated specimens and patient care when discarding rather than reprocessing takes place, and Wood's lamp or transilluminator, were omitted from the analysis.
